These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 26384640)

  • 21. An unusual cause of cerebral venous sinus thrombosis: prothrombin G20210A gene mutation.
    Porres-Aguilar M; Square JH; Storey R; Rodriguez-Dunn S; Mohamed-Aly MS
    South Med J; 2007 Sep; 100(9):906-8. PubMed ID: 17902293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Homozygous G20210A prothrombin gene mutation without thromboembolic events: a case report.
    Alatri A; Franchi F; Moia M
    Thromb Haemost; 1998 Dec; 80(6):1028-9. PubMed ID: 9869180
    [No Abstract]   [Full Text] [Related]  

  • 23. Prevalence of thrombophilia in women with severe ovarian hyperstimulation syndrome and cost-effectiveness of screening.
    Fábregues F; Tàssies D; Reverter JC; Carmona F; Ordinas A; Balasch J
    Fertil Steril; 2004 Apr; 81(4):989-95. PubMed ID: 15066453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and biochemical characterization of the prothrombin Belgrade mutation in a large Serbian pedigree: new insights into the antithrombin resistance mechanism.
    Miljic P; Gvozdenov M; Takagi Y; Takagi A; Pruner I; Dragojevic M; Tomic B; Bodrozic J; Kojima T; Radojkovic D; Djordjevic V
    J Thromb Haemost; 2017 Apr; 15(4):670-677. PubMed ID: 28075532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Genetic determinants of hereditary thrombophilia in pathogenesis of venous thrombosis].
    Kapustin SI; Blinov MN; Kargin VD; Filanovskaia LI; Saltykova NB; Beliazo OE; Golovina OG; Shmeleva VM; Panshina AM; Papaian LP
    Ter Arkh; 2003; 75(10):78-80. PubMed ID: 14669613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of the factor II G20210A mutation in symptomatic patients with inherited thrombophilia.
    De Stefano V; Chiusolo P; Paciaroni K; Casorelli I; Di Mario A; Rossi E; Leone G
    Thromb Haemost; 1998 Aug; 80(2):342-3. PubMed ID: 9716164
    [No Abstract]   [Full Text] [Related]  

  • 27. 3' end processing of the prothrombin mRNA in thrombophilia.
    Danckwardt S; Hartmann K; Gehring NH; Hentze MW; Kulozik AE
    Acta Haematol; 2006; 115(3-4):192-7. PubMed ID: 16549895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Re: "The enigma of lesion morphology in peripheral arterial occlusive disease".
    Baumann F; Diehm N
    J Endovasc Ther; 2013 Jun; 20(3):441-2. PubMed ID: 23731323
    [No Abstract]   [Full Text] [Related]  

  • 29. Stroke in an infant heterozygous carrier of both Factor V G1691A and the G20210A prothrombin mutation.
    Germanakis I; Stiakaki E; Sfyridaki C; Katampekios S; Danilatou V; Kalmanti M
    Thromb Haemost; 2003 Oct; 90(4):760-3. PubMed ID: 14515201
    [No Abstract]   [Full Text] [Related]  

  • 30. Rapid multiplex analysis for the factor V Leiden and prothrombin G20210A mutations associated with hereditary thrombophilia.
    Linfert DR; Rezuke WN; Tsongalis GJ
    Conn Med; 1998 Sep; 62(9):519-25. PubMed ID: 9785636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Familial thrombophilia and the prothrombin 20210A mutation: association with increased thrombin generation and unusual thrombosis.
    Eikelboom JW; Ivey L; Ivey J; Baker RI
    Blood Coagul Fibrinolysis; 1999 Jan; 10(1):1-5. PubMed ID: 10070829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Type and location of venous thromboembolism in carriers of Factor V Leiden or prothrombin G20210A mutation versus patients with no mutation.
    Kovac M; Mitic G; Mikovic Z; Antonijevic N; Djordjevic V; Mikovic D; Mandic V; Rakicevic L; Radojkovic D
    Clin Appl Thromb Hemost; 2010 Feb; 16(1):66-70. PubMed ID: 18796457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiology patient pages. Prothrombin 20210 mutation (factor II mutation).
    Varga EA; Moll S
    Circulation; 2004 Jul; 110(3):e15-8. PubMed ID: 15262854
    [No Abstract]   [Full Text] [Related]  

  • 34. Association of the prothrombin G20210A mutation with factor V Leiden in a midwestern American population.
    Bavikatty NR; Killeen AA; Akel N; Normolle D; Schmaier AH
    Am J Clin Pathol; 2000 Aug; 114(2):272-5. PubMed ID: 10941343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pulmonary embolism in a patient with familial thrombophilia due to homozygotic genetic mutation in 20209C>T].
    Zamora Mur A; Zamora Catevilla A; García-Foncillas López R; Fernández López L
    Med Clin (Barc); 2015 Feb; 144(4):188-9. PubMed ID: 24854192
    [No Abstract]   [Full Text] [Related]  

  • 36. Arterial thrombosis and the role of thrombophilia.
    Boekholdt SM; Kramer MH
    Semin Thromb Hemost; 2007 Sep; 33(6):588-96. PubMed ID: 17768691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prothrombin G20210A mutation is associated with recurrent pregnancy loss: a systematic review and meta-analysis update.
    Gao H; Tao FB
    Thromb Res; 2015 Feb; 135(2):339-46. PubMed ID: 25528068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The first case of antithrombin-resistant prothrombin Belgrade mutation in Japanese.
    Kishimoto M; Suzuki N; Murata M; Ogawa M; Kanematsu T; Takagi A; Kiyoi H; Kojima T; Matsushita T
    Ann Hematol; 2016 Feb; 95(3):541-2. PubMed ID: 26482463
    [No Abstract]   [Full Text] [Related]  

  • 39. Prevalence of two thrombophilia predisposing mutations: factor V G1691A (R506Q; Leiden) and prothrombin G20210A, among healthy Lebanese.
    Tamim H; Finan RR; Almawi WY
    Thromb Haemost; 2002 Oct; 88(4):691-2. PubMed ID: 12362248
    [No Abstract]   [Full Text] [Related]  

  • 40. Thrombophilia and location of venous thromboembolism.
    Schulman S
    J Thromb Haemost; 2007 Oct; 5(10):2151-2. PubMed ID: 17666017
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.